Skip to content
Laurent Pharma
  • ABOUT US
    • Leadership
    • Board of directors
    • Key advisors
  • SCIENCE
    • LAU-7b
    • Membrane Lipids
    • Resolution
  • PIPELINE
    • Overview
    • Cystic Fibrosis
    • Covid-19
  • NEWS & EVENTS
  • CONTACT
  • Fr
  • ABOUT US
    • Leadership
    • Board of directors
    • Key advisors
  • SCIENCE
    • LAU-7b
    • Membrane Lipids
    • Resolution
  • PIPELINE
    • Overview
    • Cystic Fibrosis
    • Covid-19
  • NEWS & EVENTS
  • CONTACT
  • Fr

Author: admin

This author has written 45 articles

Laurent Pharmaceuticals presents data with LAU-7b in Idiopathic Pulmonary Fibrosis at the 2024 ATS International Conference

  • Post published:13 May 2024

Laurent Pharmaceuticals presents data with LAU-7b in Idiopathic Pulmonary Fibrosis at the 2024 ATS International Conference, May 17-22, San Diego, CA, USA

Continue ReadingLaurent Pharmaceuticals presents data with LAU-7b in Idiopathic Pulmonary Fibrosis at the 2024 ATS International Conference

Laurent Pharma to participate to BIO International Convention

  • Post published:13 May 2024

Laurent Pharma to participate to BIO International Convention, June 3-6 2024, San Diego, CA, USA

Continue ReadingLaurent Pharma to participate to BIO International Convention
Read more about the article Laurent Pharmaceuticals Receives Health Canada’s Approval to Initiate Phase 2/3 Clinical Trial in Long COVID

Laurent Pharmaceuticals Receives Health Canada’s Approval to Initiate Phase 2/3 Clinical Trial in Long COVID

  • Post published:29 August 2023

The ESSOR study is a natural extension to our ongoing evaluation of LAU-7b as a next-generation COVID-19 therapeutic, which generated positive results in patients with acute COVID-19 infection and is…

Continue ReadingLaurent Pharmaceuticals Receives Health Canada’s Approval to Initiate Phase 2/3 Clinical Trial in Long COVID
← Newer Posts
Older Posts →
  • ABOUT US
    • Leadership
    • Board of directors
    • Key advisors
  • SCIENCE
    • LAU-7b
    • Membrane Lipids
    • Resolution
  • PIPELINE
    • Overview
    • Cystic Fibrosis
    • Covid-19
  • NEWS & EVENTS
  • CONTACT
  • Fr

CONTACT

  • Address:1010 Sherbrooke St West, Suite 2401 Montréal (Québec) H3A 2R7 Canada
  • Email:info@laurentpharma.comOpens in your application
Laurent Pharmaceuticals Inc. © 2025 All Rights Reserved.